Commercialization and Patents

As de-extinction technologies advance, questions arise about patenting revived species or genetic methods. Companies may seek intellectual property rights over engineered organisms, raising concerns about access, control, and the commercialization of life. Debates over who profits from these innovations and how they might impact conservation, research, and equitable sharing of genetic resources.